| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |